Opti Capital Management, LP Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$585.3B
Holdings
31
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (31 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —TERADYNE INC | 30,439 | $81.9B | 13.99% | |
| 2 | —FIREEYE INC | 52,692 | $50.0B | 8.54% | |
| 3 | —VERINT SYS INC | 47,193 | $47.1B | 8.04% | |
| 4 | NTNX 0 01/15/23NUTANIX INC | 48,043 | $42.8B | 7.31% | |
| 5 | —SUPERNUS PHARMACEUTICALS INC | 41,828 | $37.4B | 6.39% | |
| 6 | —8X8 INC NEW | 35,950 | $32.5B | 5.55% | |
| 7 | CYTK 4 11/15/26CYTOKINETICS INC | 12,500 | $29.7B | 5.07% | |
| 8 | JAZZ 1.5 08/15/24JAZZ INVESTMENTS I LTD | 31,009 | $28.5B | 4.87% | |
| 9 | —SYNAPTICS INC | 26,500 | $28.3B | 4.84% | |
| 10 | VSH 2.25 06/15/25VISHAY INTERTECHNOLOGY INC | 25,600 | $24.0B | 4.10% | |
| 11 | W 1.125 11/01/24WAYFAIR INC | 12,125 | $21.7B | 3.72% | |
| 12 | NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC | 9,000 | $15.0B | 2.56% | |
| 13 | —NEW RELIC INC | 13,215 | $12.9B | 2.20% | |
| 14 | —PTC THERAPEUTICS INC | 10,000 | $11.6B | 1.99% | |
| 15 | —RAPID7 INC | 8,500 | $11.5B | 1.96% | |
| 16 | —OMEROS CORP | 10,000 | $10.3B | 1.77% | |
| 17 | —PACIRA BIOSCIENCES | 8,545 | $9.4B | 1.60% | |
| 18 | —INFINERA CORP | 10,500 | $9.2B | 1.58% | |
| 19 | —TWITTER INC | 8,092 | $7.9B | 1.36% | |
| 20 | —WIX COM LTD | 4,218 | $7.8B | 1.34% | |
| 21 | LGND 0.75 05/15/23LIGAND PHARMACEUTICALS INC | 8,500 | $7.4B | 1.26% | |
| 22 | RMBS 1.375 02/01/23RAMBUS INC DEL | 7,000 | $7.3B | 1.24% | |
| 23 | TVTX 2.5 09/15/25RETROPHIN INC | 7,973 | $6.7B | 1.14% | |
| 24 | —PLURALSIGHT INC | 7,500 | $6.6B | 1.13% | |
| 25 | OPK 4.5 02/15/25OPKO HEALTH INC | 5,908 | $6.1B | 1.05% | |
| 26 | —REDFIN CORP | 4,000 | $5.9B | 1.02% | |
| 27 | INSM 1.75 01/15/25INSMED INC | 6,000 | $5.9B | 1.00% | |
| 28 | —II-VI INC | 4,843 | $5.8B | 0.99% | |
| 29 | NEO 1.25 05/01/25NEOGENOMICS INC | 5,000 | $5.4B | 0.93% | |
| 30 | INVA 2.125 01/15/23THERAVANCE INC | 5,200 | $5.2B | 0.88% | |
| 31 | —INTERCEPT PHARMACEUTICALS IN | 4,500 | $3.4B | 0.58% |